PD-1 or PD-L1 blockade adds little to combination of BRAF and MEK inhibition in the treatment of BRAF V600-mutated melanoma Editorial

   


Authors: Callahan, M. K.; Chapman, P. B.
Title: PD-1 or PD-L1 blockade adds little to combination of BRAF and MEK inhibition in the treatment of BRAF V600-mutated melanoma
Keywords: genetics; mutation; melanoma; skin neoplasms; protein kinase inhibitor; protein kinase inhibitors; skin tumor; b raf kinase; mitogen activated protein kinase kinase; mitogen-activated protein kinase kinases; proto-oncogene proteins b-raf; braf protein, human; programmed death 1 ligand 1; programmed death 1 receptor; humans; human; programmed cell death 1 receptor; b7-h1 antigen
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 13
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-05-01
Start Page: 1393
End Page: 1395
Language: English
DOI: 10.1200/jco.21.02801
PUBMED: 35030031
PROVIDER: scopus
PMCID: PMC9061142
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129779696&doi=10.1200%2fJCO.21.02801&partnerID=40&md5=1d90da0c11736c4c8a826f487d9b82cf
Notes: Editorial -- Export Date: 1 June 2022 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Margaret Kathleen Callahan
    197 Callahan
Related MSK Work